Vaccine and Treatment Evaluation Units: Phase IV Clinical Trial in Adults with Community Acquired Pneumonia to Assess the Effect of Early Empiric Antifungal Treatment of Coccidioidomycosis Pneumonia

Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

Key facts

NIH application ID

11177564

Project number

272201300017I-P00009-27200008-1

Recipient

DUKE UNIVERSITY

Principal Investigator

SUSANNA NAGGIE

Activity code

N01

Funding institute

NIH

Fiscal year

2024

Award amount

$93,126

Award type

—

Project period

2015-06-10 → 2024-12-31